According to Nectar Lifesciences 's latest financial reports the company's total assets are ยฃ0.20 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-03-31 | ยฃ0.20 B | -3.32% |
2023-03-31 | ยฃ0.21 B | -10.3% |
2022-03-31 | ยฃ0.23 B | 1.45% |
2021-03-31 | ยฃ0.23 B | -16.21% |
2020-03-31 | ยฃ0.28 B | -5.47% |
2019-03-31 | ยฃ0.29 B | 0.06% |
2018-03-31 | ยฃ0.29 B | -6.51% |
2017-03-31 | ยฃ0.31 B | 19.13% |
2016-03-31 | ยฃ0.26 B | 2.09% |
2015-03-31 | ยฃ0.26 B | 9.19% |
2014-03-31 | ยฃ0.24 B | -12.75% |
2013-03-31 | ยฃ0.27 B | 5.65% |
2012-03-31 | ยฃ0.26 B | 3.16% |
2011-03-31 | ยฃ0.25 B | 16.14% |
2010-03-31 | ยฃ0.21 B | 23.33% |
2009-03-31 | ยฃ0.17 B | 47.26% |
2008-03-31 | ยฃ0.11 B | 30.67% |
2007-03-31 | ยฃ91.71 M | 55.15% |
2006-03-31 | ยฃ59.11 M |